BresaGen, Cythera complete merger

By Melissa Trudinger
Friday, 09 July, 2004

The merger between Bresagen's US subsidiary Bresagen Inc and San Diego stem cell company Cythera has been completed.

The Adelaide-based company's administrators said the merger was executed on 28 June 2004.

According to the merger agreement, which was announced last month, the merger of Bresagen and Cythera was to be accompanied by a US$5 million capital raising. Bresagen (ASX:BGN) will own about 30 per cent of the combined entity and have a seat on the board.

Bresagen and Cythera initially announced the deal in November last year, but in January the Australian company went in to voluntary administration after plans to spin out its Australian protein pharmaceuticals division derailed. The division has since been acquired by Queensland-based CBio in a restructuring deal.

Related News

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...

Life expectancy gains are slowing, study finds

Life expectancy at birth in the world's longest-living populations has increased by an...

Towards safer epilepsy treatment for pregnant women

New research conducted in organoids is expected to provide pregnant women with epilepsy safer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd